At the time of writing, IO Biotech Inc [IOBT] stock is trading at $1.8, down -7.69%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IOBT shares have gain 13.92% over the last week, with a monthly amount drifted -4.76%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of IO Biotech Inc fluctuated between $0.66 and $2.79. IO Biotech Inc [NASDAQ: IOBT] shares were valued at $1.8 at the most recent close of the market.
Analyzing the IOBT fundamentals
Gross Profit Margin for this corporation currently stands at -0.28% with Operating Profit Margin at -116.71%, Pretax Profit Margin comes in at -121.26%, and Net Profit Margin reading is -122.34%. To continue investigating profitability, this company’s Return on Assets is posted at -2.46, Equity is -2.82 and Total Capital is -4.42. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of5.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.7090 points at the first support level, and at 1.6181 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9419, and for the 2nd resistance point, it is at 2.0839.
Ratios To Look Out For
It is important to note that IO Biotech Inc [NASDAQ:IOBT] has a current ratio of 1.96. In addition, the Quick Ratio stands at 1.96 and the Cash Ratio stands at 1.41.
Transactions by insiders
Recent insider trading involved Hunter Heidi, Director, that happened on May 30 ’25 when 15000.0 shares were purchased. Chief Medical Officer, Ahmad Qasim Iftikhar completed a deal on Dec 23 ’24 to buy 31350.0 shares. Meanwhile, Chief Executive Officer Zocca Mai-Britt bought 12500.0 shares on Dec 23 ’24.
